The briefing
Researchers have identified β-catenin as a key driver in an aggressive childhood bone cancer, Mirage News reports. The finding highlights a potential therapeutic target, though clinical implications remain to be established.
Original headline
β-catenin Found as Key Driver in Aggressive Childhood Bone Cancer